Search Medical Condition
Please enter condition
Please choose location from dropdown

Mt. Pleasant, South Carolina Clinical Trials

A listing of Mt. Pleasant, South Carolina clinical trials actively recruiting patient volunteers.

RESULTS

Found (593) clinical trials

Celiac disease is an inherited, life-long digestive disease affecting children and adults. When people with celiac disease eat certain foods, there is a reaction that damages their small intestine and can interfere with the ability of their intestine to take in nutrients from food. This reaction occurs when they eat ...

Phase N/A

1.13 miles

Learn More »

Gout currently affects approximately 8 million Americans. Febuxostat is an approved medication for the chronic management of Gout. The purpose of this study is to evaluate the efficacy and safety of febuxostat XR (extended release) in comparison with febuxostat IR (immediate release) in people who suffer from Gout. If you ...

Phase N/A

1.13 miles

Learn More »

You may qualify for a research study which evaluates the effectiveness and safety of an investigational medication given by injection in individuals who suffer from moderate to severe headaches and migraines. Volunteers will receive 3 doses of the study medication or placebo. This study will access the change in migraine ...

Phase N/A

1.13 miles

Learn More »

The study is evaluating the effectiveness of an investigational gel that is delivered with a pump/cap applicator for the treatment of low testosterone symptoms (such as low sex drive, low energy, mood problems, loss of muscle mass). Men who currently treat or do not treat their low testosterone are welcome ...

Phase N/A

1.13 miles

Learn More »

Coastal Carolina Research Center is evaluating the safety, tolerability, and immune response of an investigational, seasonal flu vaccine in generally healthy men and women. If you qualify for participation, you can expect 6 clinic visits and one phone call for collection of safety data over 12 months. If you are ...

Phase N/A

1.13 miles

Learn More »

Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. ...

Phase

1.13 miles

Learn More »

Study to Assess the Long Term Safety and Tolerability of ACT-541468 in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Study to assess the long term safety and tolerability of ACT-541468 in adult and elderly subjects suffering from difficulties to sleep

Phase

1.13 miles

Learn More »

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD

PTSD is a serious debilitating disorder that negatively impacts a person's daily life. PTSD is a stress-related psychiatric condition that may occur following a traumatic event such as war, disaster, sexual abuse, violence, terrorism, and accidents. PTSD negatively impacts a person's daily life, resulting in relationship difficulties, difficulty in finding ...

Phase

1.13 miles

Learn More »

Safety Tolerability and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002)

This study will evaluate the safety, tolerability, and efficacy of Human Cytomegalovirus (CMV) vaccine V160 administered in a 2-dose or 3-dose regimen in healthy seronegative women 16 to 35 years of age. Participants will receive blinded V160 on Day 1, Month 2, and Month 6 (3-dose regimen), V160 on Day ...

Phase

1.13 miles

Learn More »

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis

This is a Phase 2, randomized, multicenter, placebo-controlled study sponsored by BioMimetix JV, LLC (BMX). It is a double-blind parallel cohort study designed to determine the safety and efficacy of BMX-010 (0.03%) relative to Placebo in subjects with atopic dermatitis and psoriasis. Subjects will be queried regarding adverse events (AEs) ...

Phase

1.13 miles

Learn More »